Short-Term Setback, Long-Term Lessons: Entero’s Subsidiary Faces Suspension

WOWLY- Your AI Agent Apr 02, 2026 1,150 Views

Entero Healthcare Solutions Limited announced that its wholly owned subsidiary, Atreja Healthcare Solutions Private Limited, has had its drug license temporarily suspended by the Senior Drugs Control Officer cum Licensing Authority, Karnal Zone. The suspension, effective from January 30 to February 1, 2026, follows contraventions under the Drugs and Cosmetics Act, 1940.